The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Rise In Market Size Of The Stem Cell Manufacturing Market During The Forecast Period?
The stem cell manufacturing market has experienced rapid expansion in recent years. It is anticipated to expand from $19.17 billion in 2025 to $21.45 billion in 2026, at a compound annual growth rate (CAGR) of 11.9%. This historical growth is attributable to an increase in clinical trials, the approval of stem cell therapies, investments in bioprocessing, the evolution of regulatory frameworks, and the expansion of contract manufacturing.
The stem cell manufacturing market size is projected to experience significant expansion in the coming years. Its value is anticipated to climb to $33.55 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.8%. This projected growth throughout the forecast period stems from developments such as commercial-scale therapy production, innovations in cost reduction technologies, the emergence of decentralized manufacturing models, sophisticated cell expansion techniques, and enhanced regulatory harmonization. Furthermore, prominent trends during this period are expected to involve closed-system bioreactors, scalable manufacturing platforms, increased automation of cell expansion, the adoption of quality-by-design processes, and optimized cryopreservation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
Which Growth Factors Are Strengthening The Stem Cell Manufacturing Market Landscape?
The anticipated increase in the geriatric population is projected to accelerate the stem cell manufacturing market. This demographic comprises older adults who are 65 years old and beyond. Due to reduced immunity and age, the geriatric population is prone to various diseases. The process of aging heightens the susceptibility to chronic diseases, and stem cell manufacturing is poised to assist in combating these illnesses. For instance, in January 2024, according to the Population Reference Bureau, a Kenya-based Nonprofit organization, the number of Americans aged 65 and older is forecasted to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Furthermore, this age group’s percentage of the total population is also expected to grow from 17% to 23% during the identical period. Thus, the growing geriatric population is a significant factor driving the expansion of the stem cell manufacturing market.
How Are Different Segment Groups Identified Within The Stem Cell Manufacturing Market?
The stem cell manufacturing market covered in this report is segmented –
1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users
Subsegments:
1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits
2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers
3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)
What Trends Are Affecting The Stem Cell Manufacturing Market Dynamics?
Major companies operating within the stem cell cryopreservation market are prioritizing the creation of innovative solutions, including advanced cryopreservation media and automation-friendly freezing systems, to boost post-thaw cell viability and accelerate stem cell therapy development. Advanced cryopreservation media represent specially formulated solutions engineered to shield stem cells during freezing and thawing, thereby preserving their viability and function. Meanwhile, automation-friendly freezing systems are defined as equipment or processes crafted for scalable, reproducible, and hands-free freezing of cells in large-scale manufacturing. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze, its exclusive cryopreservation medium. This sophisticated solution is developed to optimize the freezing and thawing of pluripotent stem cells and other sensitive cell types, guaranteeing higher post-thaw viability and functional integrity. With an entirely synthetic, animal-origin-free formulation and low viscosity, PluriFreeze is perfectly suited for automated and large-scale cell production. It is complemented by the DMSO-free PluriPrep wash solution, which facilitates extended processing times. Composed of Generally Recognized as Safe (GRAS) components, the medium offers consistent, reliable, and safe cryopreservation for both research and clinical applications. By integrating seamlessly with platforms such as PluriBank, this introduction strengthens the stem cell cryopreservation workflow, providing efficient and scalable solutions from initial laboratory research to clinical implementation.
Who Are The Businesses Driving Activity In The Stem Cell Manufacturing Market?
Major companies operating in the stem cell manufacturing market are Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group
Access The Complete Stem Cell Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
Which Region Is The Primary Market For The Stem Cell Manufacturing Market?
North America was the largest region in the stem cell manufacturing market in 2025. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Stem Cell Manufacturing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp
Browse Through More Reports Similar to the Global Stem Cell Manufacturing Market 2026, By The Business Research Company
Stem Cells Therapy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Stem Cell Assay Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Induced Pluripotent Stem Cell Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model